A recent meta-analysis demonstrated a strong reduction of the recurrence risk
when immunosuppressive drugs were added to standard ATD treatment in GD patients, and the reduction of the recurrence risk
was similar in studies using corticosteroid and noncorticosteroid immunosuppressive drugs .
In this study, dichotomization of clinicopathologic variables by AUC enabled quick and easy differentiation of variables associated with high and low recurrence risk
. However, variations in breast cancer recurrence are rarely affected by a single factor.
In other words, country-specific effects are crucial in measuring conflict recurrence risk
. Another important conceptual distinction between this paper and earlier studies is the timing of the model, as we infer the risk of conflict recurrence at time t+1 by using the available information set at time t, which is an abstraction and not burdened by the problem of endogeneity often present in conflict regressions.
Our study shows a slightly higher recurrence risk
of 34.85%, Nelson et al18 similarly documented a cumulative recurrence risk
Germinal mosaicism increases the recurrence risk
for "new" Duchenne muscular dystrophy mutations.
First, because of small numbers and the study's design, no statistical tests were performed, and recurrence risk
could not be estimated.
It is important to recognise this to allow for accurate recurrence risk
estimation and genetic counselling.
However, after the birth of a child with an ASD, the empiric recurrence risk
(based on observation of thousands of families) for full siblings is between 4% and 7%.
The rate of recurrence of the AF following a successful ECV especially increases in LAVI values over 36mL/[m.sup.2], and every 1mL/[m.sup.2] increase in the LAVI was found to increase the recurrence risk
of the AF by 35%.
Data for patients with secondary VTE do demonstrate an increased recurrence risk
; when we excluded patients with cancer, the RVO studies were no longer predictive (P = 0.12).
Parents can be reassured that the recurrence risk
for future pregnancies is low, as most affected individuals have de novo mutations.
Therefore the choice of adjuvant should be according to the environmental conditions, individual recurrence risk
factors and the surgeon's expertise.